jRCT2080223786已完成2 期
A single-dose study of TMS-007 in patients with ischemic stroke (phase IIa study)
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 90
- 试验地点
- 1
- 主要终点
- Safety
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 干预模型
- A Randomized, Double-blind, Placebo-controlled, Single, Intravenous Administration, Dose-escalation Study
- 主要目的
- Treatment Purpose
入排标准
- 年龄范围
- 20age old over 至 87age old under（—）
- 性别
- All
入选标准
- •Japanese who develop symptomatic cerebral infarction
排除标准
- •1 Patients who are suitable for rt-PA or endovascular treatment
- •2 High bleeding risk
- •3 High blood pressure or high blood glucose
- •4 Severe disease affecting the pathology of ischemic stroke
- •5 Pregnancy
结局指标
主要结局
Safety
Adverse event, symptomatic intracranial hemorrhage, electrocardiogram, vital signs, laboratory tests, NIHSS, or mRS
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
2 期
A single-dose study of TMS-007 in patients with ischemic stroke (phase IIa study)Acute ischemic strokeJPRN-jRCT2080223786TMS Co., Ltd.90
已完成
不适用
Phase I, Single Dose, Dose Escalation Study of TMS-008 in Healthy Adult Male Subjectsacute kidney injuryjRCT2031240084TMS Co., Ltd.40
未知
1 期
Phase I sutdy of TMS-007Acute ischemic strokeJPRN-jRCT2080222603TMS Co., Ltd.40
已完成
不适用
Clinical trial of TRM-270 for patients undergoing pelvic cavity surgery in the field of obstetrics and gynecologyjRCT2032230476ASKA Pharmaceutical Co., Ltd.30
未知
2 期
Double-blind, Phase2 Study of TS-071 in Patients With Type 2 Diabetes Mellitus (Confirmatory Study of Dose-Response)Type 2 Diabetes MellitusJPRN-jRCT2080221156Taisho Pharmaceutical co., LTD275